Bharat Immunologicals & Biologicals Corporation Ltd.

BIBCL

₹24.34

1.29% (0.31)

Market Cap

₹105 Cr.

P/E

0.00

Bharat Immunologicals & Biologicals Corporation Ltd.
Overview
Financials
Benchmarking
Shareholding

Bharat Immunologicals & Biologicals Corporation Ltd.

Bharat Immunologicals & Biologicals Corporation Ltd.
Overview
Financials
Benchmarking
Shareholding

Quick View
Custom Financials
Forensics
Revenue Mix
Peer Comparison
Knowledge Base

About

Bharat Immunologicals & Biologicals Corp Ltd's principal activity is to manufacture and supply oral polio vaccine. The company supplies oral polio vaccine to the Government of India.The trivalent OP… Read more

Bharat Immunologicals & Biologicals Corp Ltd's principal activity is to manufacture and supply… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Company has maintained it roce despite making significant capex
ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company might have issues servicing its debt
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Asset Break-Up

Peer Comparison

FAQs on Bharat Immunologicals & Biologicals Corporation Ltd. Business

What does Bharat Immunological do?

Bharat Immunologicals & Biologicals Corp Ltd specializes in manufacturing and supplying oral polio vaccine, particularly supplying to the Government of India. The company also operates in the production of Zinc Tablets within the Healthcare sector.

Who are the competitors of Bharat Immunological?

Bharat Immunological major competitors are Makers Laboratories, Achyut Healthcare, Vaidya Sane Ayur Lab, Biofil Chem & Pharma, Murae Organisor, Ind-Swift, JFL Life Sciences.
Market Cap of Bharat Immunological is ₹104 Crs.
While the median market cap of its peers are ₹86 Crs.

Is Bharat Immunological financially stable compared to its competitors?

Bharat Immunological seems to be less financially stable compared to its competitors.
Altman Z score of Bharat Immunological is 0.73 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Bharat Immunologicals & Biologicals Corporation Ltd.